未登录
分享
收藏MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity
Cheng, Xin; Li, Jing; Tanaka, Keigo; Majumder, Utpal; Milinichik, Andrew Z.; Verdi, Arielle C.; Maddage, Christopher J.; Rybinski, Katherine A.; Fernando, Shawn; Fernando, Danielle; Kuc, Megan; Furuuchi, Keiji; Fang, Frank; Uenaka, Toshimitsu; Grasso, Luigi; Albone, Earl F.
分享
收藏
分享
收藏
分享
收藏
分享
收藏